ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,180,000 | +85.3% | 176,570 | -2.5% | 0.75% | +90.4% |
| Q1 2019 | $4,415,000 | +71.2% | 181,107 | +0.1% | 0.39% | +42.2% |
| Q4 2018 | $2,579,000 | -6.4% | 180,978 | -0.1% | 0.28% | +25.3% |
| Q3 2018 | $2,754,000 | -10.7% | 181,183 | -1.4% | 0.22% | +1.8% |
| Q2 2018 | $3,085,000 | +16.7% | 183,835 | +13.5% | 0.22% | +14.8% |
| Q1 2018 | $2,644,000 | -54.6% | 162,007 | -64.4% | 0.19% | -1.6% |
| Q4 2017 | $5,822,000 | +70.8% | 454,804 | +64.1% | 0.19% | -18.6% |
| Q3 2017 | $3,409,000 | – | 277,142 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |